TDO2 and neoplasm: Importantly, the expression of IDO1 and TDO is controlled by the AhR [214,215] and, when increased, causes depletion of local tryptophan pools in the microenvironment, suppression of antigen-specific T cell responses, and promotion of T regulatory (Treg) cell differentiation during tumor development (Figure 1C) [6].